ICUI
Price
$168.33
Change
+$7.49 (+4.66%)
Updated
Oct 22 closing price
Capitalization
4.21B
14 days until earnings call
Intraday BUY SELL Signals
IRMD
Price
$87.64
Change
-$0.17 (-0.19%)
Updated
Oct 22 closing price
Capitalization
1.12B
11 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ICUI vs IRMD

ICUI vs IRMD Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ICUI vs. IRMD commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICUI is a Buy and IRMD is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ICUI with price predictions
Oct 22, 2026

Aroon Indicator for ICUI shows an upward move is likely

ICUI's Aroon Indicator triggered a bullish signal on October 22, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 205 similar instances where the Aroon Indicator showed a similar pattern. In 155 of the 205 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 76%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ICUI's RSI Indicator exited the oversold zone, 22 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 69%.

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on ICUI as a result. In 63 of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 68%.

The Moving Average Convergence Divergence (MACD) for ICUI just turned positive on September 24, 2026. Looking at past instances where ICUI's MACD turned positive, the stock continued to rise in 36 of 51 cases over the following month. The odds of a continued upward trend are 71%.

ICUI moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +4.28% 3-day Advance, the price is estimated to grow further. Considering data from situations where ICUI advanced for three days, in 193 of 282 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 36 of 59 cases where ICUI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 61%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICUI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.

ICUI broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. ICUI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 87 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.956) is normal, around the industry mean (4.961). ICUI has a moderately high P/E Ratio (140.275) as compared to the industry average of (37.232). Projected Growth (PEG Ratio) (0.081) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (1.808) is also within normal values, averaging (56.876).

The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICUI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
a Summary for IRMD with price predictions
Oct 22, 2026

IRMD's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for IRMD turned positive on September 21, 2026. Looking at past instances where IRMD's MACD turned positive, the stock continued to rise in 43 of 52 cases over the following month. The odds of a continued upward trend are 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on IRMD as a result. In 86 of 113 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.

IRMD moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for IRMD crossed bullishly above the 50-day moving average on October 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 81%.

Following a +0.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where IRMD advanced for three days, in 192 of 263 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.

The Aroon Indicator entered an Uptrend today. In 215 of 270 cases where IRMD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 80%.

Bearish Trend Analysis

The 10-day RSI Indicator for IRMD moved out of overbought territory on October 15, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In 24 of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at 75%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 42 of 68 cases where IRMD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 62%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IRMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.

IRMD broke above its upper Bollinger Band on October 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 16 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 39 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 41 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. IRMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 87 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.014) is normal, around the industry mean (2.874). P/E Ratio (48.420) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (1.180) is also within normal values, averaging (11.052). Dividend Yield (0.009) settles around the average of (0.009) among similar stocks. P/S Ratio (12.315) is also within normal values, averaging (40.124).

The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

FUNDAMENTALS RATINGS
ICUI vs IRMD: Fundamental Ratings
ICUI
IRMD
OUTLOOK RATING
1..100
7118
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
87
Overvalued
PROFIT vs RISK RATING
1..100
10016
SMR RATING
1..100
8941
PRICE GROWTH RATING
1..100
4147
P/E GROWTH RATING
1..100
9639
SEASONALITY SCORE
1..100
n/a90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ICUI's Valuation (87) in the Medical Specialties industry is in the same range as IRMD (87). This means that ICUI’s stock grew similarly to IRMD’s over the last 12 months.

IRMD's Profit vs Risk Rating (16) in the Medical Specialties industry is significantly better than the same rating for ICUI (100). This means that IRMD’s stock grew significantly faster than ICUI’s over the last 12 months.

IRMD's SMR Rating (41) in the Medical Specialties industry is somewhat better than the same rating for ICUI (89). This means that IRMD’s stock grew somewhat faster than ICUI’s over the last 12 months.

ICUI's Price Growth Rating (41) in the Medical Specialties industry is in the same range as IRMD (47). This means that ICUI’s stock grew similarly to IRMD’s over the last 12 months.

IRMD's P/E Growth Rating (39) in the Medical Specialties industry is somewhat better than the same rating for ICUI (96). This means that IRMD’s stock grew somewhat faster than ICUI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ICUIIRMD
RSI
ODDS (%)
Bullish Trend 1 day ago
69%
Bearish Trend 1 day ago
75%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
61%
Bearish Trend 1 day ago
62%
Momentum
ODDS (%)
Bullish Trend 1 day ago
68%
Bullish Trend 1 day ago
76%
MACD
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
69%
Bearish Trend 1 day ago
64%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 11 days ago
68%
Bullish Trend 9 days ago
73%
Declines
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 1 day ago
60%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
72%
Bearish Trend 1 day ago
60%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
80%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (ICUI: $168.33 vs. IRMD: $87.81)
Brand notoriety: ICUI and IRMD are both not notable
ICUI represents the Pharmaceuticals: Other, while IRMD is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ICUI: 102% vs. IRMD: 57%
Market capitalization -- ICUI: $4.21B vs. IRMD: $1.12B
ICUI [@Pharmaceuticals: Other] is valued at $4.21B. IRMD’s [@Medical/Nursing Services] market capitalization is $1.12B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $156.8B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $173.92B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.45B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ICUI’s FA Score shows that 0 FA rating(s) are green while IRMD’s FA Score has 1 green FA rating(s).

  • ICUI’s FA Score: 0 green, 5 red.
  • IRMD’s FA Score: 1 green, 4 red.
According to our system of comparison, IRMD is a better buy in the long-term than ICUI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ICUI’s TA Score shows that 6 TA indicator(s) are bullish while IRMD’s TA Score has 6 bullish TA indicator(s).

  • ICUI’s TA Score: 6 bullish, 3 bearish.
  • IRMD’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ICUI is a better buy in the short-term than IRMD.

Price Growth

ICUI (@Pharmaceuticals: Other) experienced а +0.66% price change this week, while IRMD (@Medical/Nursing Services) price change was -2.25% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.59%. For the same industry, the average monthly price growth was -3.91%, and the average quarterly price growth was +7.47%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.

Reported Earning Dates

ICUI is expected to report earnings on Nov 05, 2026.

IRMD is expected to report earnings on Nov 02, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+0.59% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-1.62% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
ICUI
Daily Signal:
Gain/Loss:
IRMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

ICUI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICUI has been loosely correlated with CLPT. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ICUI jumps, then CLPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICUI
1D Price
Change %
ICUI100%
+4.66%
CLPT - ICUI
57%
Loosely correlated
N/A
ALGN - ICUI
50%
Loosely correlated
+2.74%
MMSI - ICUI
50%
Loosely correlated
+2.78%
A - ICUI
50%
Loosely correlated
-2.17%
BLCO - ICUI
49%
Loosely correlated
+1.46%
More

IRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRMD has been loosely correlated with HBIO. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if IRMD jumps, then HBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRMD
1D Price
Change %
IRMD100%
-0.19%
HBIO - IRMD
45%
Loosely correlated
-1.77%
PHG - IRMD
42%
Loosely correlated
+2.63%
TWST - IRMD
41%
Loosely correlated
-9.16%
ICUI - IRMD
40%
Loosely correlated
+4.66%
ATRC - IRMD
38%
Loosely correlated
+2.83%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PAYX118.816.31
+5.61%
Paychex
CVSA131.624.70
+3.70%
Covista Inc.
AKTS16.760.34
+2.07%
Aktis Oncology Inc
EVMN5.210.04
+0.77%
Evommune Inc.
PRZO0.50-0.03
-5.61%
ParaZero Technologies Ltd